A New Method for Early Screening of Gastric Cancer (G17 and CA724 Dual-Labeled Time-Resolved Fluorescence Immunoassay)
- PMID: 35912162
- PMCID: PMC9328981
- DOI: 10.1155/2022/1704948
A New Method for Early Screening of Gastric Cancer (G17 and CA724 Dual-Labeled Time-Resolved Fluorescence Immunoassay)
Retraction in
-
Retracted: A New Method for Early Screening of Gastric Cancer (G17 and CA724 Dual-Labeled Time-Resolved Fluorescence Immunoassay).Comput Math Methods Med. 2023 Oct 18;2023:9837210. doi: 10.1155/2023/9837210. eCollection 2023. Comput Math Methods Med. 2023. PMID: 37885860 Free PMC article.
Abstract
Gastric carcinoma (GC) is one of the most common malignancies in the world with the great early screening challenges. The study is aimed at establishing a new detection method for early screening GC using time-resolved fluorescence immunoassay (TRFIA) via quantitative detection of gastrin-17 (G-17) and carbohydrate antigen 724 (CA724) in serum. Time-resolved analyzer measured the fluorescence intensity. The standards of G-17/CA724 were used for drawing the standard curve, which is used to calculate the concentration of G-17 and CA724 in serum sample. The sensitivity for G-17 was 0.54 pg/mL and for CA724 was 0.28 U/mL with a wide-range analyze concentration (0.1-1000) pg/mL or U/mL. The average recoveries ranged from 100.52% to 110.30% for G-17 and 103.02% to 116.00% for CA724. All CVs of the intra- and interassay were below 10% with high specificity. There was a high Pearson coefficient between this TRFIA method and the commercially available kits (Pearson r 0.9117 for G-17 and 0.9449 for CA724). Additionally, the cutoff value was 88.41 pg/mL and 5.47 U/mL for CA724 in health subjects. This study established a TRFIA method for simultaneous detection of the concentrations of G-17 and CA724 in serum, which provide a new method for sensitive, accurate, and specific early screening of gastric cancer.
Copyright © 2022 Chang Liu et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures


Similar articles
-
Determination of serum CA724 levels using fluorescence immunochromatography.BMC Biotechnol. 2023 Aug 18;23(1):30. doi: 10.1186/s12896-023-00801-w. BMC Biotechnol. 2023. PMID: 37596558 Free PMC article.
-
[Diagnostic Value of Serum Pepsinogen Ⅰ/Pepsinogen Ⅱ Combined with Tumor Markers for Helicobacter pylori-Positive Early-Stage Gastric Cancer].Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Jan;54(1):186-191. doi: 10.12182/20230160111. Sichuan Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 36647665 Free PMC article. Chinese.
-
Time-resolved fluorescence immunoassay (TRFIA) for the simultaneous detection of hs-CRP and lipoprotein(a) in serum.Biotechnol Appl Biochem. 2022 Dec;69(6):2617-2623. doi: 10.1002/bab.2310. Epub 2022 Jan 13. Biotechnol Appl Biochem. 2022. PMID: 34981870
-
Decline of serum CA724 as a probable predictive factor for tumor response during chemotherapy of advanced gastric carcinoma.Chin J Cancer Res. 2014 Aug;26(4):404-9. doi: 10.3978/j.issn.1000-9604.2014.07.02. Chin J Cancer Res. 2014. PMID: 25232212 Free PMC article.
-
[Advances in serum biomarkers for early diagnosis of gastric cancer].Zhejiang Da Xue Xue Bao Yi Xue Ban. 2019 May 25;48(3):326-333. doi: 10.3785/j.issn.1008-9292.2019.06.14. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2019. PMID: 31496166 Free PMC article. Review. Chinese.
Cited by
-
Retracted: A New Method for Early Screening of Gastric Cancer (G17 and CA724 Dual-Labeled Time-Resolved Fluorescence Immunoassay).Comput Math Methods Med. 2023 Oct 18;2023:9837210. doi: 10.1155/2023/9837210. eCollection 2023. Comput Math Methods Med. 2023. PMID: 37885860 Free PMC article.
References
-
- Hartleb M., Wandzel P., Waluga M., Matyszczyk B., Bołdys H., Romañczyk T. Non-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and helicobacter pylori antibodies. Acta Gastroenterologica Belgica . 2004;67(4):320–326. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous